Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,033 | 25 | 53.9% |
| Food and Beverage | $22,584 | 1,239 | 27.0% |
| Consulting Fee | $9,000 | 9 | 10.8% |
| Travel and Lodging | $5,005 | 31 | 6.0% |
| Unspecified | $1,747 | 2 | 2.1% |
| Education | $164.94 | 10 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $52,536 | 180 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $8,672 | 26 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,888 | 46 | $0 (2024) |
| UCB, Inc. | $1,811 | 97 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,156 | 113 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $975.46 | 28 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $877.57 | 70 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $787.56 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $675.31 | 46 | $0 (2024) |
| MDD US Operations, LLC | $645.21 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,481 | 178 | ABBVIE INC. ($4,852) |
| 2023 | $13,041 | 168 | AbbVie Inc. ($9,232) |
| 2022 | $12,412 | 177 | ABBVIE INC. ($6,452) |
| 2021 | $8,836 | 163 | AbbVie Inc. ($3,481) |
| 2020 | $10,783 | 106 | AbbVie Inc. ($6,843) |
| 2019 | $17,528 | 238 | AbbVie, Inc. ($14,100) |
| 2018 | $10,094 | 165 | AbbVie, Inc. ($7,412) |
| 2017 | $2,358 | 121 | Medtronic USA, Inc. ($358.31) |
All Payment Transactions
1,316 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Neurology | ||||||
| 12/12/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $44.15 | General |
| Category: AMANTADINE | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Immunology and Neurology | ||||||
| 11/23/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Neurology | ||||||
| 11/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $29.15 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.15 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: Neurology | ||||||
| 11/07/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $30.50 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | Eli Lilly and Company | $547.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,589 | 8,803 | $625,145 | $194,609 |
| 2022 | 17 | 1,446 | 1,716 | $520,702 | $146,826 |
| 2021 | 18 | 1,534 | 1,810 | $574,015 | $162,988 |
| 2020 | 19 | 1,538 | 1,888 | $904,663 | $160,577 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 271 | 401 | $86,951 | $34,337 | 39.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 6,900 | $62,100 | $34,108 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 274 | $39,704 | $15,676 | 39.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 54 | 54 | $37,962 | $14,130 | 37.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 108 | 211 | $41,552 | $14,053 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $33,129 | $10,534 | 31.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 32 | 32 | $30,400 | $9,880 | 32.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 63 | 64 | $33,408 | $9,692 | 29.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 88 | 103 | $34,505 | $9,612 | 27.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 79 | 79 | $66,913 | $6,826 | 10.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 74 | 78 | $43,680 | $6,586 | 15.1% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 24 | 24 | $21,408 | $5,871 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $13,291 | $4,668 | 35.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 31 | 31 | $13,361 | $3,865 | 28.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 140 | 140 | $24,920 | $3,686 | 14.8% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2023 | 86 | 86 | $13,760 | $2,813 | 20.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 13 | 13 | $9,904 | $2,743 | 27.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 88 | 103 | $7,985 | $2,392 | 30.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 17 | 17 | $5,559 | $1,672 | 30.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 16 | 33 | $4,653 | $1,467 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 250 | 381 | $78,511 | $34,292 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 225 | 274 | $41,118 | $15,485 | 37.7% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 61 | 62 | $55,951 | $15,217 | 27.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 91 | 150 | $30,792 | $10,443 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $28,813 | $10,115 | 35.1% |
About Dr. Daniel Cobb, MD
Dr. Daniel Cobb, MD is a Neurology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457568644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Cobb, MD has received a total of $83,534 in payments from pharmaceutical and medical device companies, with $8,481 received in 2024. These payments were reported across 1,316 transactions from 78 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,033).
As a Medicare-enrolled provider, Cobb has provided services to 6,107 Medicare beneficiaries, totaling 14,217 services with total Medicare billing of $665,001. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Gainesville, GA
- Active Since 05/17/2007
- Last Updated 03/07/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1457568644
Products in Payments
- DUOPA (Drug) $27,177
- Duopa (Drug) $21,643
- Wakix (Drug) $8,606
- Briviact (Drug) $1,337
- APTIOM (Drug) $890.10
- OXTELLAR XR (Drug) $718.79
- RYTARY (Drug) $679.57
- Gamunex-C (Biological) $611.50
- NURTEC ODT (Drug) $561.99
- Gocovri (Drug) $533.77
- NUPLAZID (Drug) $517.87
- AUSTEDO (Drug) $478.21
- NUEDEXTA (Drug) $453.20
- EMGALITY (Drug) $427.98
- BOTOX (Biological) $421.05
- Fycompa (Drug) $420.24
- Aimovig (Biological) $395.99
- KESIMPTA (Drug) $394.39
- INGREZZA (Drug) $374.29
- ACTIVA (Device) $358.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Gainesville
Dr. Steven Dekosky, Md, MD
Neurology — Payments: $143,382
Dr. Michael Okun, Md, MD
Neurology — Payments: $139,637
James Wymer, Md, MD
Neurology — Payments: $48,627
Dr. Torge Rempe, M.d, M.D
Neurology — Payments: $38,279
Dr. Kathryn Moore, M.d, M.D
Neurology — Payments: $35,290
Dr. Matthew Remz, Md, MD
Neurology — Payments: $31,526